TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX-V/MIR

MedMira Inc (MIR : TSX-V)

Common Stock

$0.06

CAD

-0.01 (-7.69%)

Last updated: 2026-08-12

Get MIR alerts:

MIR

MedMira Inc

Source:WealthAwesomeWealthAwesome
$0.01 (-14.29%)
30 day period
$0.06$0.07$0.07Jun 25Jul 20Aug 12

Performance

1 Day

+0.00%

1 Week

+0.00%

1 Month

-14.29%

YTD

-7.69%

Key Statistics

Market Cap

$42.10M

52W High

$0.11

52W Low

$0.05

P/E Ratio

-

50 Day MA

$0.07

200 Day MA

$0.07

Beta

0.76

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
8/12/2026$0.06$0.06$0.06$0.06$0.061,462
8/11/2026$0.06$0.07$0.06$0.07$0.0733,462
8/10/2026$0.07$0.07$0.07$0.07$0.077,360
8/6/2026$0.06$0.06$0.06$0.06$0.0663,514
8/5/2026$0.06$0.06$0.06$0.06$0.062,000
8/4/2026$0.06$0.06$0.06$0.06$0.0650,000
7/31/2026$0.06$0.06$0.06$0.06$0.0610,462
7/30/2026$0.06$0.07$0.06$0.07$0.0721,462
7/28/2026$0.06$0.06$0.06$0.06$0.062,462
7/27/2026$0.07$0.07$0.07$0.07$0.074,500

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MIR's historical volatility

HistoricalForecast68%95%
C$0.02C$0.05C$0.09C$0.13C$0.16C$0.20TodayMar 12Jun 1Aug 12Sep 24Nov 7Dec 20

30-Day Vol

96.6%

Annualized

90-Day Vol

103.2%

Annualized

Trend (90d)

+0.0%

Annualized drift

90d Mean

C$0.06

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.06C$0.04C$0.08
60 trading daysC$0.06C$0.04C$0.10
90 trading daysC$0.06C$0.03C$0.11

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About MedMira Inc

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

Financials

Revenue (TTM)
$370,568
EBITDA
$-1.94M
Profit Margin
0.00%
ROE (TTM)
0.00%
EPS (Diluted)
0.00
Book Value
-0.04

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About MIR

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
DFSCDEFSEC Technologies Inc.$3.30+88.57%
GXGuardian Exploration Inc$0.16+52.38%
CCDCascadero Copper Corp$0.01+50.00%
NAQ-PNavigator Acquisition Corp$0.07+40.00%
PATPatriot One Technologies Inc$2.70+35.00%
ALTAlturas Minerals Corp$0.02+33.33%
CELLGrid Battery Metals Inc.$0.02+33.33%
GRIGalore Resources Inc$0.02+33.33%

MIR.V news timeline

15 articles covering MIR.V, most recent first

Latest

Why MedMira Inc stock is plummeting today

Stocks

Advertisement